Prospective comparison of the diagnostic accuracy of 18F-FDG PET/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial staging of primary breast cancer patients.


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 25 01 2021
accepted: 26 03 2021
revised: 15 03 2021
pubmed: 30 4 2021
medline: 21 10 2021
entrez: 29 4 2021
Statut: ppublish

Résumé

To compare the diagnostic performance of [ A cohort of 154 therapy-naive patients with newly diagnosed, histopathologically proven breast cancer was enrolled in this study prospectively. All patients underwent a whole-body [ Forty-one bone metastases were present in 7/154 patients (4.5%). Both [ [ • [

Identifiants

pubmed: 33912991
doi: 10.1007/s00330-021-07956-0
pii: 10.1007/s00330-021-07956-0
pmc: PMC8523471
doi:

Substances chimiques

Radiopharmaceuticals 0
Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8714-8724

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : BU3075/2-1

Informations de copyright

© 2021. The Author(s).

Références

Acta Radiol. 2011 Nov 1;52(9):1009-14
pubmed: 21969709
Eur J Radiol. 2016 Feb;85(2):459-65
pubmed: 26781152
J Comput Assist Tomogr. 1989 Jul-Aug;13(4):598-602
pubmed: 2745777
Hell J Nucl Med. 2018 May-Aug;21(2):125-133
pubmed: 30089314
Eur Radiol. 2004 Jan;14(1):99-105
pubmed: 12845463
Chin Clin Oncol. 2020 Apr;9(2):18
pubmed: 32036675
Radiol Bras. 2017 Jul-Aug;50(4):211-215
pubmed: 28894327
Skeletal Radiol. 2011 May;40(5):523-31
pubmed: 20495798
NPJ Breast Cancer. 2018 Jan 25;4:2
pubmed: 29387785
Breast. 2008 Feb;17(1):98-103
pubmed: 17890090
Acta Oncol. 2016;55(1):59-67
pubmed: 25833330
Ann Oncol. 2015 Sep;26 Suppl 5:v8-30
pubmed: 26314782
Magn Reson Med. 2013 Oct;70(4):1047-57
pubmed: 23203976
Geburtshilfe Frauenheilkd. 2018 Nov;78(11):1056-1088
pubmed: 30581198
Cancer Causes Control. 2012 Jan;23(1):103-12
pubmed: 22037907
J Clin Oncol. 1998 Jun;16(6):2038-44
pubmed: 9626201
Nucl Med Rev Cent East Eur. 2013;16(2):66-9
pubmed: 24068635
Mol Imaging Biol. 2020 Apr;22(2):397-406
pubmed: 31236756
Rofo. 2009 Mar;181(3):255-63
pubmed: 19229791
BMC Cancer. 2015 Jul 10;15:512
pubmed: 26156521
Medicine (Baltimore). 2017 Dec;96(50):e8985
pubmed: 29390293
J Natl Compr Canc Netw. 2018 Mar;16(3):310-320
pubmed: 29523670
J Nucl Med. 2015 Apr;56(4):560-6
pubmed: 25745091
Br J Cancer. 2015 Apr 28;112(9):1452-60
pubmed: 25871331
Radiologe. 2000 Sep;40(9):826-34
pubmed: 11056975
Ann Oncol. 2020 Dec;31(12):1623-1649
pubmed: 32979513
J Nucl Med. 2017 Nov;58(11):1778-1785
pubmed: 28798033
J Clin Oncol. 2010 Jul 1;28(19):3154-9
pubmed: 20516453
Breast Cancer Res Treat. 2016 Apr;156(3):587-595
pubmed: 27083181
Rofo. 2011 Dec;183(12):1130-7
pubmed: 22068844
Br J Radiol. 1983 Apr;56(664):233-6
pubmed: 6831145
Ann Oncol. 2018 Aug 1;29(8):1634-1657
pubmed: 30032243
Eur J Nucl Med Mol Imaging. 2018 Apr;45(4):622-629
pubmed: 29164299
Q J Nucl Med. 2001 Mar;45(1):53-64
pubmed: 11456376
Eur J Radiol. 2011 Jun;78(3):430-5
pubmed: 19945240
J Clin Oncol. 2016 Jun 1;34(16):1889-97
pubmed: 27001573
Dtsch Arztebl Int. 2014 Oct 31;111(44):741-7
pubmed: 25412631
Br J Cancer. 1987 Jan;55(1):61-6
pubmed: 3814476
Radiology. 2012 Dec;265(3):910-6
pubmed: 23093680

Auteurs

Nils Martin Bruckmann (NM)

Department of Diagnostic and Interventional Radiology, Medical Faculty, University Dusseldorf, Moorenstrasse 5, D-40225, Dusseldorf, Germany. nils-m.bruckmann@web.de.

Julian Kirchner (J)

Department of Diagnostic and Interventional Radiology, Medical Faculty, University Dusseldorf, Moorenstrasse 5, D-40225, Dusseldorf, Germany.

Lale Umutlu (L)

Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University of Duisburg-Essen, D-45147, Essen, Germany.

Wolfgang Peter Fendler (WP)

Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, D-45147, Essen, Germany.

Robert Seifert (R)

Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, D-45147, Essen, Germany.

Ken Herrmann (K)

Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, D-45147, Essen, Germany.

Ann-Kathrin Bittner (AK)

Department Gynecology and Obstetrics, University Hospital Essen, University of Duisburg-Essen, D-45147, Essen, Germany.

Oliver Hoffmann (O)

Department Gynecology and Obstetrics, University Hospital Essen, University of Duisburg-Essen, D-45147, Essen, Germany.

Svjetlana Mohrmann (S)

Department of Gynecology, Medical Faculty, University Dusseldorf, D-40225, Dusseldorf, Germany.

Christina Antke (C)

Department of Nuclear Medicine, Medical Faculty, University Dusseldorf, 40225, Dusseldorf, Germany.

Lars Schimmöller (L)

Department of Diagnostic and Interventional Radiology, Medical Faculty, University Dusseldorf, Moorenstrasse 5, D-40225, Dusseldorf, Germany.

Marc Ingenwerth (M)

Institute of Pathology, University Duisburg-Essen and the German Cancer Consortium (DKTK), University Hospital Essen, West German Cancer Center, Essen, Germany.

Katharina Breuckmann (K)

Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University of Duisburg-Essen, D-45147, Essen, Germany.

Andreas Stang (A)

Institute of Medical Informatics, Biometry and Epidemiology, University Hospital of Essen, Essen, Germany.

Christian Buchbender (C)

Department of Diagnostic and Interventional Radiology, Medical Faculty, University Dusseldorf, Moorenstrasse 5, D-40225, Dusseldorf, Germany.

Gerald Antoch (G)

Department of Diagnostic and Interventional Radiology, Medical Faculty, University Dusseldorf, Moorenstrasse 5, D-40225, Dusseldorf, Germany.

Lino M Sawicki (LM)

Department of Diagnostic and Interventional Radiology, Medical Faculty, University Dusseldorf, Moorenstrasse 5, D-40225, Dusseldorf, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH